EpitalonExperimental peptide
Epitalon, also spelled Epithalon, is a synthetic four-amino-acid peptide discussed in ageing research. Its reputation rests largely on laboratory work and a limited clinical literature.
What is Epitalon?
Epitalon, also spelled Epithalon, is a synthetic four-amino-acid peptide associated with ageing research. It should be distinguished from the pineal-gland extracts discussed in some older studies.
How it works
Experimental work examines telomerase, telomere-related markers and other cellular processes. Changing a cellular ageing marker does not establish longer human life.
Effects studied
What does the evidence show?
The archive collects studies of cellular ageing, animal outcomes and small human investigations. It does not establish a dependable longevity or sleep benefit.
What the name refers to
Epitalon is associated with research on pineal-gland extracts, but the synthetic peptide and those extracts are not identical preparations. That distinction matters when a claim cites an older study: evidence about a mixture should not automatically be assigned to a four-amino-acid molecule.
The appeal of telomeres
Telomeres help protect chromosome ends, and their maintenance is one part of cell biology. Some experimental work asks whether epitalon influences telomerase or related markers. A laboratory change does not tell us whether a person will avoid disease, sleep better or live longer. Those outcomes require human studies designed to measure them. 1 2
What human studies would need to establish
A convincing clinical programme would define the preparation, recruit comparable groups, measure meaningful outcomes and follow participants long enough to detect both benefit and harm. The archived material leaves major gaps in each of these areas. Short-term biomarker findings cannot fill them.
What an online listing cannot answer
Purity, identity and sterility are not demonstrated by a research-use label. Nor does a discussion about compounding establish an approved indication. This draft does not adopt the archive’s time-sensitive regulatory claims; any such status needs a current primary-source check for the actual product and country.
Safety & status
Long-term human safety remains insufficiently characterised in the material reviewed. Research-use labels do not establish identity, purity or sterility of products.
Country and product status
This introduction describes the molecule and its research context. Product availability, approved indications and eligibility in Germany and Switzerland require a current local product check; they are not established by an overseas study or an online listing.
Frequently asked questions
Is a telomerase change proof of longer life?
No. It is a biological observation; disease, function and survival need to be measured in suitable human studies.
Can pineal-extract studies be counted as epitalon studies?
Only if they actually tested the same defined substance. A tissue extract and a synthetic four-amino-acid peptide are different preparations.
Further reading
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Epitalon: pubmed.ncbi.nlm.nih.gov reference Research reference · Retained archive reference; not independently checked for this draft.
- Epitalon: paper 10.1023/a:1025493705728 Research reference · Retained archive reference; not independently checked for this draft.
- Epitalon: paper 10.1023/a:1021104819170 Research reference · Retained archive reference; not independently checked for this draft.
- Epitalon: pubmed.ncbi.nlm.nih.gov reference Research reference · Retained archive reference; not independently checked for this draft.
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.